Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Adelis and other shareholders in connection with the sale of Logent
Mandate

Vinge advises Adelis and other shareholders in connection with the sale of Logent

May 24, 2019 M&A

Vinge advises Adelis and other shareholders in connection with the sale of Logent to Stirling Square Capital Partners.

Logent is an independent contract logistics partner to logistics-intensive companies in Sweden and Norway. Logent has approximately 3,000 employees and operates along the whole logistics value chain within the business areas Warehousing, Transport Management, Customs, Ports, Staffing & Recruitment and Consulting.

Closing of the transaction is subject to the Swedish Competition Authority's approval. 

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Samra Baytar, Manne Bergström andTove Lövgren Frisk and VDR Specialist Viktoria Owets. 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026